Bausch Health Companies Inc. (BHC)
$5.86
$-0.21
(-3.46%)
As on 11-Sep-2026 16:00EDT
Market cap
$2,192 Mln
Revenue (TTM)
$10,853 Mln
P/E Ratio
--
P/B Ratio
18.8
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$67 Mln
-
ROE
0.4 %
-
ROCE
-- %
-
Industry P/E
16.53
-
EV/EBITDA
10.5
-
Debt to Equity
-11.2
-
Book Value
$-4.7
-
EPS
$-3
-
Face value
--
-
Shares outstanding
373,990,561
10 Years Aggregate
CFO
$14,715.10 Mln
EBITDA
$33,656.00 Mln
Net Profit
$-7,588.70 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bausch Health Companies (BHC)
| -15.7 | -7.7 | 13.8 | -18.0 | -12.1 | -27.1 | -14.5 |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Bausch Health Companies (BHC)
| -13.8 | 27.7 | -77.3 | 32.7 | -30.5 | 62.0 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bausch Health Companies (BHC)
|
5.9 | 2,191.6 | 10,853.0 | -1,098.0 | 8.1 | -- | -- | 18.8 |
| 5.1 | 1,014.3 | 181.7 | 153.1 | 84.3 | 91.3 | 6.5 | 3.9 | |
| 3.7 | 236.8 | 290.3 | -110.7 | -23.9 | -21.7 | -- | 0.6 | |
| 0.9 | 416.8 | 321.4 | -259.3 | -71.1 | -30 | -- | 0.8 | |
| 2.0 | 233.1 | 0.0 | -36.7 | -- | -174.9 | -- | 13.5 | |
| 3.1 | 1,156.8 | 242.8 | 69.8 | 10.4 | 5.6 | 16.5 | 1.1 | |
| 1.8 | 1.1 | 41.4 | -15.8 | -24.6 | -- | -- | 0.9 | |
| 1.1 | 151.4 | 309.1 | 86.6 | -2.2 | 18.7 | 2.4 | 0.4 | |
| 3.2 | 20.6 | 0.0 | -24.9 | -- | -333.3 | -- | 0.0 | |
| 1.3 | 329.8 | 928.4 | -21.7 | -2.0 | -2 | -- | 0.4 |
Shareholding Pattern
View DetailsAbout Bausch Health Companies (BHC)
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures,... and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. Read more
-
CEO & Director
Mr. Thomas J. Appio
-
CEO & Director
Mr. Thomas J. Appio
-
Headquarters
Laval, QC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Bausch Health Companies (BHC)
What is the current share price of Bausch Health Companies Inc (BHC) Today?
The share price of Bausch Health Companies Inc (BHC) is $5.86 (NYSE) as of 11-Sep-2026 16:00 EDT. Bausch Health Companies Inc (BHC) has given a return of -12.14% in the last 3 years.
What is the current PB & PE ratio of Bausch Health Companies Inc (BHC)?
Since, TTM earnings of Bausch Health Companies Inc (BHC) is negative, P/E ratio is not available.
The P/B ratio of Bausch Health Companies Inc (BHC) is 18.78 times as on 11-Sep-2026, a 379 premium to its peers’ median range of 3.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
16.40 |
-4.66 |
2024 |
-65.18 |
-2.34 |
2023 |
-4.95 |
-2.87 |
2022 |
-10.10 |
-3.28 |
2021 |
-10.60 |
-295.67 |
What is the 52 Week High and Low of Bausch Health Companies Inc (BHC)?
The 52-week high and low of Bausch Health Companies Inc (BHC) are Rs 8.00 and Rs 4.33 as of 14-Sep-2026.
What is the market cap of Bausch Health Companies Inc (BHC)?
Bausch Health Companies Inc (BHC) has a market capitalisation of $ 2,192 Mln as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bausch Health Companies Inc (BHC)?
Before investing in Bausch Health Companies Inc (BHC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.